C12N 2740/15022
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2740/15022 (New viral proteins or individual genes, new structural or functional aspects of) appears on 391 US grants and 355 published applications in this corpus.
Search patents in C12N- Granted patents
- 391
- Published applications
- 355
- Assignees
- 281
- Inventors
- 823
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 6 | 0 |
| 1995 | 7 | 0 |
| 1996 | 13 | 0 |
| 1997 | 19 | 0 |
| 1998 | 34 | 0 |
| 1999 | 25 | 0 |
| 2000 | 33 | 0 |
| 2001 | 23 | 6 |
| 2002 | 18 | 12 |
| 2003 | 18 | 40 |
| 2004 | 10 | 18 |
| 2005 | 8 | 26 |
| 2006 | 22 | 23 |
| 2007 | 8 | 20 |
| 2008 | 11 | 15 |
| 2009 | 8 | 14 |
| 2010 | 16 | 18 |
| 2011 | 9 | 21 |
| 2012 | 11 | 16 |
| 2013 | 7 | 6 |
| 2014 | 11 | 5 |
| 2015 | 11 | 16 |
| 2016 | 7 | 11 |
| 2017 | 6 | 3 |
| 2018 | 15 | 10 |
| 2019 | 3 | 6 |
| 2020 | 4 | 3 |
| 2021 | 6 | 8 |
| 2022 | 2 | 14 |
| 2023 | 2 | 6 |
| 2024 | 1 | 15 |
| 2025 | 7 | 14 |
| 2026 | 2 | 9 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Spike-in reference standard for use in detecting sample target from DNA or RNA organism26 May 2026US 12,637,726 B2Gene Copoeia, Inc.
- Compositions for treating cancer14 Oct 2025US 12,440,564 B2Kelonia Therapeutics, Inc.
- Compositions for treating cancer2 Sep 2025US 12,403,194 B2Kelonia Therapeutics, Inc.
- SIV envelope trimer26 Aug 2025US 12,398,177 B2The Scripps Research Institute
- Recombinant retrovirus, compositions, and methods of use30 Jul 2026US 2026/0218136 A1Kelonia Therapeutics, Inc.
- Systems and methods for modifying a polynucleotide9 Jul 2026US 2026/0193679 A1Children's Medical Center Corporation
- Stabilization of human immunodeficiency virus (hiv) envelopes11 Jun 2026US 2026/0158133 A1
- Lymphocyte targeted lentiviral vectors11 Jun 2026US 2026/0159853 A1Kelonia Therapeutics, Inc.
- Targeting vector, preparation method therefor and use thereof21 May 2026US 2026/0137811 A1Shenzhen Genocury Biotech Co., Ltd.
Most cited
By later US patents
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996
- Eukaryotic layered vector initiation systems204US 5,814,482 A1998
- Alphavirus vector constructs167US 5,843,723 AChiron Corporation · 1998
- Alphavirus structural protein expression cassettes152US 5,789,245 AChiron Corporation · 1998
- Adeno-associated virus materials and methods146US 5,658,785 AChildren's Hospital, Inc. · 1997